SCHEMBL7979145

SCHEMBL7979145

CC1CC1c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.43
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
SIRT2 Q8IXJ6 14/20 0.37
FLT3 P36888 1/20 0.35
TYRO3 Q06418 1/20 0.35
MERTK Q12866 1/20 0.35
GAS6 Q14393 1/20 0.35
KCNJ6 P48051 1/20 0.31
KCNJ5 P48544 1/20 0.31
KCNJ3 P48549 1/20 0.31
CYP3A4 P08684 2/20 0.30
MEN1 O00255 1/20 0.30
SLC22A1 O15245 1/20 0.30
KCNN4 O15554 1/20 0.30
NR1I2 O75469 1/20 0.30
GMNN O75496 1/20 0.30
USP2 O75604 1/20 0.30
TRPM2 O94759 1/20 0.30
ABCB11 O95342 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30210402 1.00 ENPP2 (0.43) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL8846372 0.86 ENPP2 (0.44) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL7779691 0.85 ENPP2 (0.43) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL8846588 0.85 ENPP2 (0.43) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL8846420 0.85 ENPP2 (0.43) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL7784260 0.85 ENPP2 (0.43) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL7779693 0.85 ENPP2 (0.43) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL8846444 0.82 ENPP2 (0.42) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL8846881 0.82 ENPP2 (0.42) ENPP2CYP11B1CYP11B2SIRT2FLT3
SCHEMBL6703350 0.80 ENPP2 (0.40) ENPP2CYP11B1CYP11B2SIRT2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117024411-B Isoquinoline as HPK1 inhibitor 豪夫迈·罗氏有限公司 2026-05-19 CN disclosed
CN-110709392-B Isoquinoline as HPK1 inhibitor 豪夫迈·罗氏有限公司 2023-09-29 CN disclosed
US-11566003-B2 Isoquinolines as inhibitors of HPK1 GENENTECH, INC. (US) 2023-01-31 US disclosed
WO-2001081317-A1 CHIRAL IMIDAZOYL INTERMEDIATES FOR THE SYNTHESIS OF 2-(4-IMIDAZOYL)-CYCLOPROPYL DERIVATIVES GLIATECH, INC. (US) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566003-B2 Isoquinolines as inhibitors of HPK1 HIPK1, HIPK2, IP6K1 ENPP2 853/4885CYP11B1 3472/4885CYP11B2 3429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.